New diabetes clinical trial: Dual GIP/GLP-1 Receptor Agonist in Obese Women Before Frozen Embryo Transfer

Published on: 2026-09-10T04:00:00Z
Conditions: Tirzepatide; Frozen Embryo Transfer; Obesity
Interventions: Drug: Dual GIP/GLP-1 receptor agonist
Sponsors: RenJi Hospital; Shandong University; Shanghai Zhongshan Hospital; Shenyang Women's and Children's Hospital; Third Affiliated Hospital of Zhengzhou University; Henan Provincial People's Hospital; The Second Hospital of Hebei Medical University; Jiangsu Provincial People's Hospital; Shanghai First Maternity and Infant Hospital; West China Second University Hospital; Nanjing Maternity and Child Health Care Hospital; Anhui Provincial Hospital; Northwest Women's and Children's Hospital, Xi'an, Shaanxi; Shenyang Jinghua Hospital; The First Affiliated Hospital of Anhui Medical University; The First Affiliated Hospital of Zhengzhou University; Tongji Hospital; The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School; Tianjin Central Hospital of Gynecology Obstetrics; Ningbo Women & Children's Hospital
Not yet recruiting
https://ift.tt/efrz9uU